Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Shimada

Showing results (71-80 of 383) with videos related to

Pageof 39
Sort By:
Annals of Gastroenterological Surgery|August 2, 2021
Clinical TNM staging for esophageal, gastric, and colorectal cancers in the era of neoadjuvant therapy: A systematic review of the literatureHideaki Shimada, Takeo Fukagawa, Yoshio Haga, et al.
Digestive Surgery|June 10, 2011
Apparent diffusion coefficient values measured by diffusion-weighted imaging predict chemoradiotherapeutic effect for advanced esophageal cancerTomoyoshi Aoyagi, Kiyohiko Shuto, Shinichi Okazumi, et al.
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|January 26, 2011
Angiogenesis-related factors are molecular targets for diagnosis and treatment of patients with esophageal carcinomaYoko Oshima, Satoshi Yajima, Kunihiro Yamazaki, et al.
Journal of Bioscience and Bioengineering|March 21, 2007
Possibility of insulin-producing cells derived from mouse embryonic stem cells for diabetes treatmentTakahisa Ibii, Hideaki Shimada, Suguru Miura, et al.
Drug Design, Development and Therapy|November 19, 2009
Gene medicine for cancer treatment: commercially available medicine and accumulated clinical data in ChinaGuangyu Ma, Hideaki Shimada, Kenzo Hiroshima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 26, 2015
[Liquid Biopsy in Multimodal Treatment of Esophageal Carcinoma]Hideaki Shimada, Satoshi Yajima, Yoko Oshima, et al.
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP|November 30, 2002
Sex-dependent pharmacokinetics of S(-)-hydroxyhexamide, a pharmacologically active metabolite of acetohexamide, in ratsYorishige Imamura, Miho Kaneko, Hidenori Takada, et al.
Diseases (Basel, Switzerland)|February 25, 2025
Clinical Impact of Olaparib for Platinum-Sensitive Recurrent Ovarian CancerHiroaki Ishida, Megumi Manrai, Akiko Takashima, et al.
Cancer Science|February 19, 2021
Multipanel assay of 17 tumor-associated antibodies for serological detection of stage 0/I breast cancerMakoto Sumazaki, Hideaki Ogata, Yoshihiro Nabeya, et al.
Frontiers in Bioscience (Landmark Edition)|June 11, 2013
Novel type III interferons produce anti-tumor effects through multiple functionsQuanhai Li, Kiyoko Kawamura, Yuji Tada, et al.
Pageof 39

Showing results (71-80 of 383) with videos related to

Sort By:
Pageof 39
Annals of Gastroenterological Surgery|August 2, 2021
Clinical TNM staging for esophageal, gastric, and colorectal cancers in the era of neoadjuvant therapy: A systematic review of the literatureHideaki Shimada, Takeo Fukagawa, Yoshio Haga, et al.
Digestive Surgery|June 10, 2011
Apparent diffusion coefficient values measured by diffusion-weighted imaging predict chemoradiotherapeutic effect for advanced esophageal cancerTomoyoshi Aoyagi, Kiyohiko Shuto, Shinichi Okazumi, et al.
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|January 26, 2011
Angiogenesis-related factors are molecular targets for diagnosis and treatment of patients with esophageal carcinomaYoko Oshima, Satoshi Yajima, Kunihiro Yamazaki, et al.
Journal of Bioscience and Bioengineering|March 21, 2007
Possibility of insulin-producing cells derived from mouse embryonic stem cells for diabetes treatmentTakahisa Ibii, Hideaki Shimada, Suguru Miura, et al.
Drug Design, Development and Therapy|November 19, 2009
Gene medicine for cancer treatment: commercially available medicine and accumulated clinical data in ChinaGuangyu Ma, Hideaki Shimada, Kenzo Hiroshima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 26, 2015
[Liquid Biopsy in Multimodal Treatment of Esophageal Carcinoma]Hideaki Shimada, Satoshi Yajima, Yoko Oshima, et al.
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP|November 30, 2002
Sex-dependent pharmacokinetics of S(-)-hydroxyhexamide, a pharmacologically active metabolite of acetohexamide, in ratsYorishige Imamura, Miho Kaneko, Hidenori Takada, et al.
Diseases (Basel, Switzerland)|February 25, 2025
Clinical Impact of Olaparib for Platinum-Sensitive Recurrent Ovarian CancerHiroaki Ishida, Megumi Manrai, Akiko Takashima, et al.
Cancer Science|February 19, 2021
Multipanel assay of 17 tumor-associated antibodies for serological detection of stage 0/I breast cancerMakoto Sumazaki, Hideaki Ogata, Yoshihiro Nabeya, et al.
Frontiers in Bioscience (Landmark Edition)|June 11, 2013
Novel type III interferons produce anti-tumor effects through multiple functionsQuanhai Li, Kiyoko Kawamura, Yuji Tada, et al.
Pageof 39